InvestorsHub Logo
Followers 51
Posts 3931
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Saturday, 06/23/2018 10:07:31 AM

Saturday, June 23, 2018 10:07:31 AM

Post# of 457078
Partial list of Companies that failed trials for Alzheimer’s Disease;

Axovant
Merck
Eli Lilly/AstraZeneca
Pfizer
J&J
Prana
Biogen on the ropes
Neurochem
Boehringer
Takeda/Zinfandel
Roche

Some are hoping the same fate will befall Anavex thinking, these great companies failed, how can little Anavex succeed? No one can make any headway against Alzheimer’s.

Fortunately for them, they are wrong as the evidence continues to mount in Anavex’s favor growing ever closer to beginning the final stage trial leading to approval.

With the 32 person trial showing all 8 of 8 patients complaining of insomnia being relieved after taking A2-73, Alzheimer’s finally has a contender in the ring that will win a few rounds with this disease. Am I leaving anything out? Yes. 2-73 has many more things going for it. Most have been enumerated on this forum adinfinitum.

IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News